Laurell A B, Mårtensson U, Sjöholm A G
Department of Medical Microbiology, University of Lund, Sweden.
J Immunol. 1987 Dec 15;139(12):4145-51.
Activation of the C1 complex in the presence of C1 inactivator (C1 IA) is known to result in the formation of tetramer C1 IA-C1r-C1s-C1 IA complexes that are dissociated from C1q. Both C1r and C1s of the tetramers are present in their activated forms. The present investigation concerned the generation of trimer complexes containing C1 IA, activated C1r, and zymogen C1s (C1 IA-C1r-C1s). C1 IA-C1r-C1s were released from C1q and were formed in high concentration during prolonged incubation (1 to 3 days) of normal serum at 37 degrees C without addition of activators. By contrast, dissociation of C1 with formation of C1 IA-C1r-C1s-C1 IA was complete within 30 min at 37 degrees C, when the serum was treated with heat-aggregated IgG (1 g/liter). On size exclusion chromatography (TSK-4000), C1 IA-C1r-C1s and C1 IA-C1r-C1s-C1 IA emerged with apparent m.w. of 320,000 and 460,000, respectively. The composition of the complexes was examined by absorption of serum with F(ab')2 anti-C1s- or anti-C1r-coated Sepharose beads. Eluates were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis combined with immunoblotting. Under nonreducing conditions, heat-aggregated IgG-treated serum showed high concentrations of C1 IA-C1r (m.w. 202,000) and C1 IA-C1s (m.w. 194,000), while serum incubated at 37 degrees C without activators showed high concentrations of C1 IA-C1r but no C1 IA-C1s. Under reducing conditions, heat-aggregated IgG-treated serum showed m.w. 120,000 and 110,000 complexes of C1 IA and the C1r and C1s light chains, respectively. Uncleaved C1s and the m.w. 120,000 complex was found in serum that was incubated at 37 degrees C without activators. Consistent with results obtained by size exclusion chromatography, analysis by crossed immunoelectrophoresis and by electroimmunoassay showed that C1s could be released from C1 IA-C1r-C1s in the presence of EDTA.
已知在存在C1灭活剂(C1 IA)的情况下C1复合物的激活会导致形成从C1q解离的四聚体C1 IA - C1r - C1s - C1 IA复合物。四聚体中的C1r和C1s均以其活化形式存在。本研究关注含有C1 IA、活化的C1r和酶原C1s(C1 IA - C1r - C1s)的三聚体复合物的产生。C1 IA - C1r - C1s从C1q释放出来,并且在正常血清于37℃长时间孵育(1至3天)且不添加激活剂的情况下以高浓度形成。相比之下,当血清用热聚集的IgG(1 g/升)处理时,C1解离并形成C1 IA - C1r - C1s - C1 IA在37℃下30分钟内完成。在尺寸排阻色谱(TSK - 4000)上,C1 IA - C1r - C1s和C1 IA - C1r - C1s - C1 IA分别以表观分子量320,000和460,000出现。通过用F(ab')2抗C1s或抗C1r包被的琼脂糖珠吸收血清来检查复合物的组成。通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳结合免疫印迹分析洗脱液。在非还原条件下,经热聚集的IgG处理的血清显示高浓度的C1 IA - C1r(分子量202,000)和C1 IA - C1s(分子量194,000),而在37℃无激活剂孵育的血清显示高浓度的C1 IA - C1r但无C1 IA - C1s。在还原条件下,经热聚集的IgG处理的血清分别显示C1 IA与C1r和C1s轻链的分子量为120,000和110,000的复合物。在37℃无激活剂孵育的血清中发现未切割 的C1s和分子量120,000的复合物。与尺寸排阻色谱获得的结果一致,交叉免疫电泳和免疫电泳分析表明在EDTA存在下C1s可从C1 IA - C1r - C1s中释放出来。